MultiBank Group Wins ‘Best Mobile FX Trading App’ at Qatar Financial Expo 2025
MultiBank Group, the world’s largest financial derivatives institution headquartered in Dubai, took home the ‘Best Mobile FX Trading App’ award for the MultiBank Plus App at the Qatar Financial Expo 2025 in Doha, held from February 4-5.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250226810034/en/
MultiBank Group Wins Best Mobile FX Trading App at Qatar Financial Expo 2025 (Graphic: Business Wire)
The Qatar Financial Expo is a prestigious global event that gathers leading institutions and industry experts to showcase innovations in the financial services sector. This win underscores MultiBank Group’s commitment to delivering cutting-edge, user-centric solutions that empower clients worldwide.
Commenting on the achievement, Naser Taher, Founder and Chairman of MultiBank Group, said: “We are delighted to receive the ‘Best Mobile FX Trading App’ award. This recognition reflects our relentless focus on innovation and our dedication to providing clients with seamless, secure, and advanced trading experiences. We remain at the forefront of technological advancements to meet the evolving needs of our global clientele.”
The award-winning app provides access to over 20,000 financial instruments, including forex, metals, commodities, shares, indices, UAE CFDs and digital assets. With its intuitive interface, sophisticated charting tools, and real-time market execution, it offers a superior trading experience on the go. Additionally, MultiBank Plus app benefits from strong regulatory oversight and cutting-edge technology, embodying MultiBank Group’s emphasis on transparency, reliability, and convenience.
The ‘Best Mobile FX Trading App’ award further reinforces the firm’s reputation as an innovator in the fintech space, driving the future of mobile solutions with excellence and integrity.
Since its establishment in 2005, MultiBank Group has expanded to serve over 2 million clients across 100 countries, with a daily trading volume exceeding $25.6 billion. With a presence in key global hubs and a portfolio of more than 70 industry awards, the Group continues to solidify its position as a trusted leader in derivatives.
ABOUT MULTIBANK GROUP
MultiBank Group, established in California, USA in 2005, is a global leader in financial derivatives, serving over 2 million clients across 100 countries, and boasts a daily trading volume that exceeds $25.6 billion. Renowned for its innovative trading solutions, robust regulatory compliance, and exceptional customer service, the Group offers an array of brokerage services and asset management solutions. It is regulated across five continents by 17+ of the most reputable financial authorities globally. The group’s award-winning trading platforms offer up to 500:1 leverage on a diverse range of products, including Forex, Metals, Shares, Commodities, Indices, and Cryptocurrencies. MultiBank Group has received over 70 financial awards recognizing its trading excellence and regulatory compliance. For more information, visit MultiBank Group’s website.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250226810034/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cirium Introduces First AI-Powered Solution for On-Time Performance Analysis24.6.2025 11:00:00 CEST | Press release
Cirium, the global leader in aviation analytics, has launched OTP Improvement AI, a groundbreaking generative AI-powered solution designed to transform how airlines and airports analyze and enhance their On-Time Performance (OTP). This innovative tool addresses long-standing challenges in operational efficiency and disruption management, offering faster, smarter, and more proactive decision-making capabilities. OTP Improvement AI sets itself apart by addressing the specific challenges airlines and airports face, such as the time-intensive nature of traditional OTP analysis and the struggle to manage cascading delays caused by factors like weather or technical issues. By using advanced generative AI, the platform transforms complex data into precise insights, enabling operators to trends, streamline resources, and make swift decisions that minimize delays and improve the overall passenger experience. “Operational disruptions, whether caused by weather, strikes, or unforeseen technical i
Zambon Announces Approval and Launch in China of the Intravenous Formulation of Fluimucil® (N-acetylcysteine)24.6.2025 10:00:00 CEST | Press release
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profileThe launch strengthens Zambon's presence in China and marks a significant step in the company’s commitment to global therapeutic innovation in respiratory diseases, reflecting its dedicated focus on both clinical research and patient care Zambon, a multinational chemical-pharmaceutical company founded on the history and values of an Italian family and committed to innovate cure and care to make patients’ lives better, announces the approval by Chinese regulatory authorities and the launch on the Chinese market of the intravenous (IV) formulation of Fluimucil® (N-acetylcysteine). This milestone marks a significant step in the company’s commitment to global therapeutic innovation in respiratory diseases, reflecting its dedicated focus on both clinical research and patient care. Already available in several international markets, Fluimucil® IV r
Imperva Application Security Integrates API Detection and Response, Setting A New Standard in API Security24.6.2025 09:00:00 CEST | Press release
First unified, single-pane-of-glass platform to deliver real-time detection and mitigation of API threats, including Broken Object Level Authorization (BOLA) and other advanced business logic threats Offers flexible deployment across cloud and on-premise environments, with a privacy-forward design to secure APIs at scale. Thales today announced new detection and response capabilities in the Imperva Application Security platform to protect against business logic attacks, such as Broken Object Level Authorization (BOLA) – the leading threat in the OWASP API Security Top 10. By integrating real-time detection with automated mitigation of risky APIs, BOLA attacks, unauthenticated APIs, and deprecated APIs, Imperva Application Security platform delivers comprehensive protection against unauthorized data exposure and other complex business logic vulnerabilities across cloud and on-premises environments. APIs have become the backbone of modern applications, enabling businesses to seamlessly c
SWARM Biotactics Raised €13M to Advance Bio-Robotics From Lab to Field24.6.2025 08:43:00 CEST | Press release
SWARM Biotactics, developer of bio-robotic systems based on fully controllable living insects for mission-critical operations, has secured €10 million in seed funding, bringing its total raised to €13 million, including a €3 million pre-seed. The round was backed by a consortium of international investors from Europe, the United States, and Australia, including Vertex Ventures US, Possible Ventures, and Capnamic, who was the first investor in the pre-seed round. Several early backers also increased their stakes in the oversubscribed round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623790761/en/ A SWARM Biotactics bio-robotic unit equipped with a custom sensor backpack for intelligence gathering in inaccessible terrain. (Photo: SWARM Biotactics) UNMATCHED ACCESS FOR CRITICAL MISSIONS SWARM Biotactics is creating a new category of robotics: living, intelligent systems designed for environments where machines can’t go—c
Bloom Announces Early 2026 UK Launch, Expanding into Europe with New Garden Pharma as Exclusive Manufacturer24.6.2025 07:05:00 CEST | Press release
The Bloom Brand, a recognized U.S. leader in cannabis vape, is making its international debut in the United Kingdom through an exclusive partnership with New Garden Pharma, a leading European EU-GMP cannabis operator. Together, the two companies will launch Bloom’s award-winning Classic and Live vape collections in the UK in Q1 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250623573625/en/ This marks Bloom’s first international market expansion, as the company continues its global growth strategy with additional EU markets in development for 2026 and beyond. UK patients will gain access to Bloom’s superior formulations and proprietary hardware systems. For more than a decade, Bloom has built its reputation on delivering terpene-rich, flavor-forward strains paired with reliable technology. The brand has an established and leading presence across leading U.S. markets including California, Illinois, Florida, Michigan, Mi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom